Article Details
Retrieved on: 2025-02-04 17:17:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a lead.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here